부산대학교 도서관

Ascierto, P.A.; Bifulco, C.; Ciardiello, F.; Demaria, S.; Emens, L.A.; Ferris, R.; Formenti, S.C.; Galon, J.; Khleif, S.N.; Kirchhoff, T.; McQuade, J.; Odunsi, K.; Patnaik, A.; Paulos, C.M.; Taube, J.M.; Timmerman, J.; Fox, B.A.; Hwu, P.; Puzanov, I.

In: Journal of Translational Medicine. (Journal of Translational Medicine, December 2021, 19(1))

Haymaker C; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Johnson DH; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Murthy R; Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Bentebibel SE; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Uemura MI; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Hudgens CW; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Safa H; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; James M; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Andtbacka RHI; Surgical Oncology Department of Surgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.; Johnson DB; Division of Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.; Shaheen M; Department of Medicine and Cancer Center, University of Arizona, Tucson, Arizona.; Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Rahimian S; Idera Pharmaceuticals, Inc., Exton, Pennsylvania.; Chunduru SK; Idera Pharmaceuticals, Inc., Exton, Pennsylvania.; Milton DR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Tetzlaff MT; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Overwijk WW; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Gabrail N; Department of Oncology, Gabrail Cancer Center, Canton, Ohio.; Agrawal S; Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts.; Doolittle G; Department of Oncology, University of Kansas Medical Center, Kansas City, Kansas.; Puzanov I; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Markowitz J; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.; Bernatchez C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. adiab@mdanderson.org cbernatchez@mdanderson.org.; Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. adiab@mdanderson.org cbernatchez@mdanderson.org.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

Lindsay, C. R.; Chan, E.; Evans, T. R.; Campbell, S.; Bell, P.; Stephens, A. W.; Franke, A.; Poondru, S.; Rothenberg, M. L.; Puzanov, I.

JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2009, 27 15, 2p. Supplement: S

Ascierto, P.A.; Brody, J.; Butterfield, L.H.; Finn, O.J.; Goldberg, J.; Perrone, F.; Sullivan, R.J.; Fox, B.A.; Hwu, P.; Puzanov, I.

In: Journal of Translational Medicine. (Journal of Translational Medicine, December 2021, 19(1))

Palmieri G; University of Sassari & Unit of Cancer Genetics, National Research Council (CNR), Sassari, Italy.; Puzanov I; Roswell Park Comprehensive Cancer Center, University of Buffalo, Buffalo, NY, United States.; Massi D; Section of Pathology, Department of Health Sciences, University of Florence, Florence, Italy.; Ascierto PA; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Tolcher, A. W.; Rothenberg, M. L.; Rodon, J.; Delbeke, D.; Patnaik, A.; Nguyen, L.; Young, F.; Hwang, Y.; Haqq, C.; Puzanov, I.

JOURNAL OF CLINICAL ONCOLOGY; JUN 20 2007, 25 18, 2p. Supplement: S

Switzer B; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.; Haanen J; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Lorigan PC; Division of Cancer Sciences, The University of Manchester, Manchester, UK.; Division of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.; Puzanov I; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA igor.puzanov@roswellpark.org samra.turajlic@crick.ac.uk.; Turajlic S; Renal and Skin Units, Royal Marsden NHS Foundation Trust, London, UK igor.puzanov@roswellpark.org samra.turajlic@crick.ac.uk.; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Kazantseva, L. K.; Seretkin, Yu. V.; Puzanov, I. S.

GLASS AND CERAMICS; JAN 2018, 74 9-10, p372-p377, 6p.

Puzanov, I.; Havenith, K.; Boni, J.; Cruz, H.G.; Anderson, K.; Kopotsha, T.; Le Bruchec, Y.; Bendell, J.C.; Kummar, S.; Papadopoulos, K.P.; LoRusso, P.; Wuerthner, J.

In Annals of Oncology September 2020 31 Supplement 4:S710-S711

Ascierto PA; Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Via Mariano Semmola, 80131, Naples, Italy. paolo.ascierto@gmail.com.; Puzanov I; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Agarwala SS; Temple University School of Medicine, Philadelphia, PA, USA.; Blank C; Netherlands Cancer Institute, Amsterdam, The Netherlands.; Carvajal RD; Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center, New York, NY, USA.; Demaria S; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA.; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.; Dummer R; Department of Dermatology, University of Zurich Hospital, Zurich, Switzerland.; Ernstoff M; Roswell Park Comprehensive Cancer Center, Jacobs School of Medicine and Biomedical Sciences, State University, Buffalo, NY, USA.; Ferrone S; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Fox BA; Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Cancer Institute, Portland, OR, USA.; Gajewski TF; Department of Pathology, University of Chicago, Chicago, IL, USA.; Department of Medicine (Section of Haematology/Oncology), University of Chicago, Chicago, IL, USA.; Garbe C; Center for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tübingen, Germany.; Hwu P; Department of Melanoma Medical Oncology, Division of Cancer Medicine, Anderson Cancer Center, Houston, TX, USA.; Lo RS; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.; Long GV; Melanoma Institute Australia, The University of Sydney and Royal North Shore and Mater Hospitals, Sydney, Australia.; Luke JJ; Medicine University of Chicago, Chicago, IL, USA.; Osman I; The Interdisciplinary Melanoma Program, New York University Langone Medical Center, NYU Grossman Medical School, New York, NY, USA.; Postow MA; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.; Sullivan RJ; Melanoma Program, Mass General Cancer Center, Boston, MA, USA.; Taube JM; Division of Dermatopathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Trinchieri G; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Zarour HM; Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.; Caracò C; Department Melanoma, Soft Tissue, Muscle-Skeletal and Head-Neck, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy.; Thurin M; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, MD, USA.

Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE